Kafka died in 1924 of tuberculosis, which remains one of the world’s deadliest infectious diseases. This talk looks at the various aspects of tuberculosis from candidate vaccines, the role of genetics in TB treatments and the perspective of a patient.
Tuberculosis remains one of the world’s deadliest infectious diseases, not least because of the prevalence of drug-resistant strains of TB. Researchers at the University of Oxford, supported by the NIHR Oxford Biomedical Research Centre (BRC), are tackling TB in a variety of ways, from vaccines to more targeted treatments.
Speakers:
Professor Helen McShane: Director of the Oxford NIHR Biomedical Research Centre; Professor of Vaccinology at Oxford University; Deputy Head (Translation and Personnel), Medical Sciences Division; and an Honorary Consultant Physician in Infectious Diseases.
Dr Philip Fowler: Associate Professor in the Modernising Medical Microbiology consortium in the Nuffield Department of Medicine; Cellular Life, Nuffield Department of Medicine
Produced by the NIHR Oxford Biomedical Research Centre.
